Schroepfer G J, Kim H S, Vermilion J L, Stephens T W, Pinkerton F D, Needleman D H, Wilson W K, St Pyrek J
Department of Biochemistry, Rice University, Houston, Texas 77251.
Biochem Biophys Res Commun. 1988 Feb 29;151(1):130-6. doi: 10.1016/0006-291x(88)90568-2.
The enzymatic (rat liver mitochondria) conversion of 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one to 5 alpha-cholest-8(14)-ene-3 beta,26-diol-15-one is described. The enzymatic product was judged, on the basis of IH and 13C NMR studies, to be a 4:1 mixture of its 25R and 25S isomers. (25R)-5 alpha-Cholest-8(14)-ene-3 beta,26-diol-15-one was prepared through a five-step synthesis from (25R)-26-hydroxycholesterol. The (25R) isomer of the new compound was found to be highly active in the suppression of the levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured mammalian cells and to inhibit the esterification of cholesterol in jejunal microsomes.